The current health care reform efforts have been summarized by some as being focused on 2 goals: social justice and value.1 These goals are highly interdependent, particularly in our current economic state. The ability to distinguish among a broad array of potential approaches and interventions based on their varying value becomes a required enabler of increasing access (social justice), while balancing cost and quality (value). Comparative effectiveness research (CER) is an essential element for success in these pursuits and is also vital to the future of biopharmaceutical development.
Murray RK, McElwee NE. Comparative Effectiveness ResearchCritically Intertwined With Health Care Reform and the Future of Biomedical Innovation. Arch Intern Med. 2010;170(7):596–599. doi:10.1001/archinternmed.2010.50